113 related articles for article (PubMed ID: 25754817)
1. miR-5100 promotes tumor growth in lung cancer by targeting Rab6.
Huang H; Jiang Y; Wang Y; Chen T; Yang L; He H; Lin Z; Liu T; Yang T; Kamp DW; Wu B; Liu G
Cancer Lett; 2015 Jun; 362(1):15-24. PubMed ID: 25754817
[TBL] [Abstract][Full Text] [Related]
2. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
Wang R; Wang ZX; Yang JS; Pan X; De W; Chen LB
Oncogene; 2011 Jun; 30(23):2644-58. PubMed ID: 21358675
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1.
Hwang SJ; Lee HW; Kim HR; Song HJ; Lee DH; Lee H; Shin CH; Joung JG; Kim DH; Joo KM; Kim HH
Oncotarget; 2015 Aug; 6(24):20434-48. PubMed ID: 25971210
[TBL] [Abstract][Full Text] [Related]
5. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
Xu J; Li Y; Wang F; Wang X; Cheng B; Ye F; Xie X; Zhou C; Lu W
Oncogene; 2013 Feb; 32(8):976-87. PubMed ID: 22469983
[TBL] [Abstract][Full Text] [Related]
6. miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma.
Wang Y; Chen T; Huang H; Jiang Y; Yang L; Lin Z; He H; Liu T; Wu B; Chen J; Kamp DW; Liu G
Oncotarget; 2017 Mar; 8(12):20133-20144. PubMed ID: 28423618
[TBL] [Abstract][Full Text] [Related]
7. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E
Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1.
Gu H; Yang T; Fu S; Chen X; Guo L; Ni Y
Biochem Biophys Res Commun; 2014 Jan; 444(1):104-8. PubMed ID: 24440705
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer.
Cao J; Song Y; Bi N; Shen J; Liu W; Fan J; Sun G; Tong T; He J; Shi Y; Zhang X; Lu N; He Y; Zhang H; Ma K; Luo X; Lv L; Deng H; Cheng J; Zhu J; Wang L; Zhan Q
Cancer Res; 2013 Jun; 73(11):3326-35. PubMed ID: 23592755
[TBL] [Abstract][Full Text] [Related]
10. MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6.
Yang L; Lin Z; Wang Y; Gao S; Li Q; Li C; Xu W; Chen J; Liu T; Song Z; Liu G
Mol Carcinog; 2018 Mar; 57(3):419-428. PubMed ID: 29144562
[TBL] [Abstract][Full Text] [Related]
11. Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4.
He J; Zhang W; Zhou Q; Zhao T; Song Y; Chai L; Li Y
Int J Biochem Cell Biol; 2013 Sep; 45(9):1962-73. PubMed ID: 23811124
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer.
Xu L; Huang Y; Chen D; He J; Zhu W; Zhang Y; Liu X
Cancer Genet; 2014 May; 207(5):214-20. PubMed ID: 24906642
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
14. Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells.
Ren XS; Yin MH; Zhang X; Wang Z; Feng SP; Wang GX; Luo YJ; Liang PZ; Yang XQ; He JX; Zhang BL
Cancer Lett; 2014 Mar; 344(2):195-203. PubMed ID: 24211326
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2.
Zhao Z; Liu J; Wang C; Wang Y; Jiang Y; Guo M
Int J Clin Exp Pathol; 2014; 7(11):7726-34. PubMed ID: 25550809
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH
Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231
[TBL] [Abstract][Full Text] [Related]
17. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
Wang N; Zhou Y; Zheng L; Li H
Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
[TBL] [Abstract][Full Text] [Related]
18. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.
Zhu W; Shan X; Wang T; Shu Y; Liu P
Int J Cancer; 2010 Dec; 127(11):2520-9. PubMed ID: 20162574
[TBL] [Abstract][Full Text] [Related]
19. miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBPβ.
Zhang XF; Li KK; Gao L; Li SZ; Chen K; Zhang JB; Wang D; Tu RF; Zhang JX; Tao KX; Wang G; Zhang XD
Oncotarget; 2015 Feb; 6(6):4144-58. PubMed ID: 25784653
[TBL] [Abstract][Full Text] [Related]
20. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]